Follow us on:

CVS

CVS Health Corporation – Consensus ‘buy’ rating and 11.3% Upside Potential

February 14, 2025

CVS Health Corporation – Consensus ‘buy’ rating and 15.3% Upside Potential

January 31, 2025

CVS Health Corporation – Consensus ‘buy’ rating and 23.6% Upside Potential

January 22, 2025

CVS Health Corporation – Consensus ‘buy’ rating and 24.5% Upside Potential

January 17, 2025

CVS Health Corporation Share Price Target ‘$64.94’, now 41.7% Upside Potential

January 8, 2025

CVS Health Corporation – Consensus ‘buy’ rating and 47.6% Upside Potential

January 3, 2025

CVS Health Corporation Share Price Target ‘$67.11’, now 51.3% Upside Potential

December 24, 2024

CVS Health Corporation Share Price Target ‘$68.35’, now 32.1% Upside Potential

December 13, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 20.2% Upside Potential

December 9, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 14.2% Upside Potential

December 3, 2024

CVS Health Corporation Share Price Target ‘$68.35’, now 15.8% Upside Potential

November 28, 2024

CVS Health Corporation Share Price Target ‘$68.35’, now 19.7% Upside Potential

November 25, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 29.2% Upside Potential

November 19, 2024

CVS Health Corporation Share Price Target ‘$68.90’, now 27.0% Upside Potential

November 15, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 18.4% Upside Potential

November 11, 2024

CVS Health Corporation Share Price Target ‘$67.39’, now 20.1% Upside Potential

October 28, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 15.7% Upside Potential

October 23, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 3.3% Upside Potential

October 4, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 10.8% Upside Potential

September 27, 2024

CVS Health Corporation Share Price Target ‘$63.95’, now 7.8% Upside Potential

September 6, 2024

News and Interview Alerts

Company Presentations

Cerillion PLC Annual Results 2024 ‘Record Highs’, Louis Hall CEO

Norcros Plc

Norcros Plc CEO and CFO Present Interim Results to 30 September 2024 (LON:NXR)

Ilika plc: A New Era in Solid-State Battery Innovation – 2024 Investor Presentation

Time Finance PLC Strong Growth and Strategic Progress: A Message from CEO Ed Rimmer

Q&As

Elemental Royalty Corporation

Elemental Royalty CEO David Cole on merger synergies and global royalty growth

17 December 2025

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Green News

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Real Estate Credit Investments

Real Estate Credit Investments: Why 95% of Investors Voted to Stay In While Rivals Wind Down (Video)

Real Estate Credit Investments Profiting From the Blind Spots in Property Lending (Video)

NB Private Equity Returns Stay Strong as Exit Pipeline Builds and Buybacks Accelerate (Video)

Cora Gold Funding Boost Fuels Sanankoro’s Push Toward Key Permit Milestone (Video)

BrokerTalk

Fidelity

How FCSS is harnessing China’s innovation – Kepler Research

15 January 2026

Fidelity

Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research

15 January 2026

JPMorgan European Discovery Trust plc

JPMorgan European Discovery Trust (JEDT) Latest Research, January 2026

8 January 2026

Pharos Energy

Pharos Energy Strengthens Position in Egypt and Vietnam, Says Cavendish

8 January 2026

Funds

Global Opportunities Trust

Global Opportunities Trust: Cash builds as valuations rise | New Research

28 January 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Cranswick PLC (CWK.L) Stock Analysis: Exploring a Promising 11.33% Potential Upside

4 February 2026

Clarkson PLC (CKN.L) Stock Analysis: Riding the Waves of Marine Shipping with a 4.75% Upside

4 February 2026

Coats Group PLC (COA.L) Stock Analysis: Exploring 35.98% Potential Upside with Strong Buy Ratings

4 February 2026

Chrysalis Investments Limited (CHRY.L) Stock Analysis: Unpacking a 54.69% Upside Potential

4 February 2026

Big Yellow Group PLC (BYG.L) Stock Analysis: Exploring a 19% Potential Upside Amidst Strong Dividend Yield

4 February 2026

May 27, 2021

CVS Health Corporation – Consensus ‘buy’ rating and 11.3% Upside Potential

February 14, 2025

CVS Health Corporation – Consensus ‘buy’ rating and 15.3% Upside Potential

January 31, 2025

CVS Health Corporation – Consensus ‘buy’ rating and 23.6% Upside Potential

January 22, 2025

CVS Health Corporation – Consensus ‘buy’ rating and 24.5% Upside Potential

January 17, 2025

CVS Health Corporation Share Price Target ‘$64.94’, now 41.7% Upside Potential

January 8, 2025

CVS Health Corporation – Consensus ‘buy’ rating and 47.6% Upside Potential

January 3, 2025

CVS Health Corporation Share Price Target ‘$67.11’, now 51.3% Upside Potential

December 24, 2024

CVS Health Corporation Share Price Target ‘$68.35’, now 32.1% Upside Potential

December 13, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 20.2% Upside Potential

December 9, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 14.2% Upside Potential

December 3, 2024

CVS Health Corporation Share Price Target ‘$68.35’, now 15.8% Upside Potential

November 28, 2024

CVS Health Corporation Share Price Target ‘$68.35’, now 19.7% Upside Potential

November 25, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 29.2% Upside Potential

November 19, 2024

CVS Health Corporation Share Price Target ‘$68.90’, now 27.0% Upside Potential

November 15, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 18.4% Upside Potential

November 11, 2024

CVS Health Corporation Share Price Target ‘$67.39’, now 20.1% Upside Potential

October 28, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 15.7% Upside Potential

October 23, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 3.3% Upside Potential

October 4, 2024

CVS Health Corporation – Consensus ‘buy’ rating and 10.8% Upside Potential

September 27, 2024

CVS Health Corporation Share Price Target ‘$63.95’, now 7.8% Upside Potential

September 6, 2024

News and Interview Alerts

Company Presentations

Cerillion PLC Annual Results 2024 ‘Record Highs’, Louis Hall CEO

Norcros Plc

Norcros Plc CEO and CFO Present Interim Results to 30 September 2024 (LON:NXR)

Ilika plc: A New Era in Solid-State Battery Innovation – 2024 Investor Presentation

Time Finance PLC Strong Growth and Strategic Progress: A Message from CEO Ed Rimmer

Q&As

Elemental Royalty Corporation

Elemental Royalty CEO David Cole on merger synergies and global royalty growth

17 December 2025

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Green News

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest interviews

Real Estate Credit Investments

Real Estate Credit Investments: Why 95% of Investors Voted to Stay In While Rivals Wind Down (Video)

Real Estate Credit Investments Profiting From the Blind Spots in Property Lending (Video)

NB Private Equity Returns Stay Strong as Exit Pipeline Builds and Buybacks Accelerate (Video)

Cora Gold Funding Boost Fuels Sanankoro’s Push Toward Key Permit Milestone (Video)

Broker Talk

Fidelity

How FCSS is harnessing China’s innovation – Kepler Research

15 January 2026

Fidelity

Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research

15 January 2026

JPMorgan European Discovery Trust plc

JPMorgan European Discovery Trust (JEDT) Latest Research, January 2026

8 January 2026

Pharos Energy

Pharos Energy Strengthens Position in Egypt and Vietnam, Says Cavendish

8 January 2026

Funds

Global Opportunities Trust

Global Opportunities Trust: Cash builds as valuations rise | New Research

28 January 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Cranswick PLC (CWK.L) Stock Analysis: Exploring a Promising 11.33% Potential Upside

4 February 2026

Clarkson PLC (CKN.L) Stock Analysis: Riding the Waves of Marine Shipping with a 4.75% Upside

4 February 2026

Coats Group PLC (COA.L) Stock Analysis: Exploring 35.98% Potential Upside with Strong Buy Ratings

4 February 2026

Chrysalis Investments Limited (CHRY.L) Stock Analysis: Unpacking a 54.69% Upside Potential

4 February 2026

Big Yellow Group PLC (BYG.L) Stock Analysis: Exploring a 19% Potential Upside Amidst Strong Dividend Yield

4 February 2026

CVS

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 11.3% Upside Potential

14 February 2025

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 15.3% Upside Potential

31 January 2025

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 23.6% Upside Potential

22 January 2025

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 24.5% Upside Potential

17 January 2025

Broker Ratings

CVS Health Corporation Share Price Target ‘$64.94’, now 41.7% Upside Potential

8 January 2025

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 47.6% Upside Potential

3 January 2025

Broker Ratings

CVS Health Corporation Share Price Target ‘$67.11’, now 51.3% Upside Potential

24 December 2024

Broker Ratings

CVS Health Corporation Share Price Target ‘$68.35’, now 32.1% Upside Potential

13 December 2024

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 20.2% Upside Potential

9 December 2024

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 14.2% Upside Potential

3 December 2024

Broker Ratings

CVS Health Corporation Share Price Target ‘$68.35’, now 15.8% Upside Potential

28 November 2024

Broker Ratings

CVS Health Corporation Share Price Target ‘$68.35’, now 19.7% Upside Potential

25 November 2024

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 29.2% Upside Potential

19 November 2024

Broker Ratings

CVS Health Corporation Share Price Target ‘$68.90’, now 27.0% Upside Potential

15 November 2024

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 18.4% Upside Potential

11 November 2024

Broker Ratings

CVS Health Corporation Share Price Target ‘$67.39’, now 20.1% Upside Potential

28 October 2024

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 15.7% Upside Potential

23 October 2024

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 3.3% Upside Potential

4 October 2024

Broker Ratings

CVS Health Corporation – Consensus ‘buy’ rating and 10.8% Upside Potential

27 September 2024

Broker Ratings

CVS Health Corporation Share Price Target ‘$63.95’, now 7.8% Upside Potential

6 September 2024

Latest Interviews

Real Estate Credit Investments

Real Estate Credit Investments: Why 95% of Investors Voted to Stay In While Rivals Wind Down (Video)

5 January 2026

Real Estate Credit Investments Profiting From the Blind Spots in Property Lending (Video)

5 January 2026

NB Private Equity Returns Stay Strong as Exit Pipeline Builds and Buybacks Accelerate (Video)

19 December 2025

Cora Gold Funding Boost Fuels Sanankoro’s Push Toward Key Permit Milestone (Video)

18 December 2025

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Company Presentations

Cerillion PLC Annual Results 2024 ‘Record Highs’, Louis Hall CEO

9 December 2024

Norcros Plc

Norcros Plc CEO and CFO Present Interim Results to 30 September 2024 (LON:NXR)

5 December 2024

Ilika plc: A New Era in Solid-State Battery Innovation – 2024 Investor Presentation

28 October 2024

Time Finance PLC Strong Growth and Strategic Progress: A Message from CEO Ed Rimmer

24 October 2024

Q&As

Elemental Royalty Corporation

Elemental Royalty CEO David Cole on merger synergies and global royalty growth

17 December 2025

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

BrokerTalk

Fidelity

How FCSS is harnessing China’s innovation – Kepler Research

15 January 2026

Fidelity

Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research

15 January 2026

JPMorgan European Discovery Trust plc

JPMorgan European Discovery Trust (JEDT) Latest Research, January 2026

8 January 2026

Pharos Energy

Pharos Energy Strengthens Position in Egypt and Vietnam, Says Cavendish

8 January 2026

FTSE 100

Funds

Global Opportunities Trust

Global Opportunities Trust: Cash builds as valuations rise | New Research

28 January 2026

View all Funds, Market Insights and news >>

Green News

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

UK Broker Ratings

Cranswick PLC (CWK.L) Stock Analysis: Exploring a Promising 11.33% Potential Upside

4 February 2026

Clarkson PLC (CKN.L) Stock Analysis: Riding the Waves of Marine Shipping with a 4.75% Upside

4 February 2026

Coats Group PLC (COA.L) Stock Analysis: Exploring 35.98% Potential Upside with Strong Buy Ratings

4 February 2026

Chrysalis Investments Limited (CHRY.L) Stock Analysis: Unpacking a 54.69% Upside Potential

4 February 2026

Big Yellow Group PLC (BYG.L) Stock Analysis: Exploring a 19% Potential Upside Amidst Strong Dividend Yield

4 February 2026